CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
CroíValve is creating DUO 4 All, a minimally invasive device aimed at treating severe Tricuspid Regurgitation, a common heart valve disease. This innovative solution addresses specific challenges associated with Tricuspid Regurgitation, focusing on patient safety, effectiveness, and ease of use for healthcare providers…
CroíValve is developing DUO 4 All, a Best-In-Class minimally invasive solution for severe Tricuspid Regurgitation (TR).
It is a clear unmet clinical need, with significant impact on mortality, cardiovascular events and quality of life of the large population suffering with this disease.
With the highest prevalence of all heart valve diseases, TR is a significant clinical and commercial opportunity.
It poses unique challenges in comparison with other heart valve diseases and so needs a solution s…
CROIVALVE LIMITED
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
